當(dāng)前位置:上海普邁生物科技有限公司>>試劑>> BioLog代理BioLog Life Science上海代理
| 參 考 價 | 面議 |
產(chǎn)品型號BioLog代理
品 牌
廠商性質(zhì)代理商
所 在 地上海市
聯(lián)系方式:蔣先生查看聯(lián)系方式
更新時間:2021-03-23 18:09:33瀏覽次數(shù):628次
聯(lián)系我時,請告知來自 儀表網(wǎng)BioLog Life Science代理,BioLog Life Science中國代理,BioLog Life Science上海代理,BioLog Life Science北京代理,BioLog Life Science廣州代理,BioLog Life Science代理,BioLog Life Science
| Cyclic diguanosine monophosphorodithioate, Rp- isomers ( Rp,Rp-c-diGMPSS ) | 1259875-41-6 | |
| C 130 | Cyclic diguanosine monophosphorodithioate, Rp- / Sp- isomers ( Rp,Sp-c-diGMPSS ) | 1259875-47-2 |
| C 132 | 2'- / 3'- O- (5- Chloroanthraniloyl)inosine- 5'- O- triphosphate ( Cl-ANT-ITP ) | 1350521-48-0 |
| C 136 | 4- Cyclopentyl- 2- (2, 5- dimethylbenzylsulfanyl)- 6- oxo- 1, 6- dihydropyrimidine- 5- carbonitrile ( HJC0197 ) | 1383539-73-8 |
| C 145 | Cyclic (adenosine monophosphate- 8- bromoguanosine monophosphate) ( c-(Ap-8-Br-Gp) / 8-Br-cGAMP ) | pending |
| C 146 | 8- Chloro- cyclic diadenosine monophosphate ( 8-Cl-c-diAMP ) | pending |
| C 149 | Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate) ( c-(Ap-8-AET-Gp) / 8-AET-cGAMP ) | pending |
| C 157 | Cyclic (adenosine monophosphate- 8- (2- [biotinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-[Biotin]-AET-Gp) / 8-[Biotin]-AET-cGAMP ) | pending |
| C 159 | Cyclic (adenosine monophosphate- 8- (2- [fluoresceinyl]aminoethylthio)guanosine monophosphate) ( c-(Ap-8-Fluo-AET-Gp) / 8-Fluo-AET-cGAMP ) | pending |
| C 161 | Cyclic (guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[G(2',5')pA(3',5')p] / cGAMP(2'-5') / 2'3'-cGAMP / 2',5'-3',5'-cGAMP ) | 1441190-66-4 |
| C 162 | Cyclic diguanosine- (2' −> 5')- monophosphate / cyclic bis (2' −> 5') diguanylic acid ( c[G(2',5')pG(2',5')p] / 2',5'-2',5'-c-diGMP / c-diGMP(2'-5') ) | 389873-75-0 |
| C 166 | Cyclic (adenosine monophosphate- 8- (2- aminoethylthio)guanosine monophosphate), immobilized on agarose gel ( c-(Ap-8-AET-Gp)-Agarose ) | none |
| C 172 | Cyclic (8- bromoguanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-Br-G(2',5')pA(3',5')p] ) | pending |
| C 175 | Cyclic (8- (2- aminoethylthio)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-AET-G(2',5')pA(3',5')p] ) | pending |
| C 176 | Cyclic (8- (2- [biotinyl]aminoethylthio)- guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-[Biotin]-AET-G(2',5')pA(3',5')p] ) | pending |
| C 178 | Cyclic (8- (2- [fluoresceinyl]aminoethylthio)- guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[8-Fluo-AET-G(2',5')pA(3',5')p] / 8-Fluo-AET-cGAMP(2'-5') ) | pending |
| D 001 | 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) | 142754-31-2 |
| D 002 | 2', 3'- Dideoxyadenosine ( ddA ) | 4097-22-7 |
| D 003 | 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) | 64145-26-2 |
| D 004 | 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) | 120496-69-7 |
| D 005 | 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) | 120496-69-7 |
| D 006 | 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) | 87358-15-4 |
| D 007 | 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) | 80875-87-2 |
| D 008 | N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) | 159910-48-2 |
| D 009 | N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade | 16980-89-5 |
| D 009 E | N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade | 16980-89-5 |
| D 010 | N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) | 51116-00-8 |
| D 011 | 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) | 129693-10-3 |
| D 012 | 5, 6- Dichloro- 1- ß- D- ribofuranosyl benzimidazole ( DRB ) | 53-85-0 |
| D 013 | 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) | 120912-55-2 |
| D 014 | 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) | 120912-54-1 |
| D 015 | 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) | 93839-95-3 |
| D 016 | N², N²- Dimethylguanosine ( m22Guo ) | 2140-67-2 |
| D 018 | 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) | 132619-65-9 |
| D 019 | 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) | 68726-28-3 |
| D 020 | 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) | 93919-42-7 |
| D 021 | 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) | 16719-36-1 |
| D 022 | 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) | 88847-89-6 |
| D 025 | 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate) ( ddGTP-α-S ) | 154771-50-3 |
| D 026 | 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate) ( ddATP-α-S ) | 154902-26-8 |
| D 027 | 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate) ( ddCTP-α-S ) | 154771-49-0 |
| D 028 | 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate) ( ddUTP-α-S ) | 1053668-88-4 |
| D 029 | 3'- Deoxythymidine- 5'- O- (1- thiotriphosphate) ( dTTP-α-S ) / 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate) ( ddTTP-α-S ) | 154771-48-9 |
| D 030 | 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) | 80902-29-0 |
| D 031 | 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) | 80902-28-9 |
| D 032 | 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP / 5'-TuMP ), sodium salt | 16719-46-3 |
| D 033 | 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) | 67460-15-5 |
| D 037 | 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) | 132619-66-0 |
| D 038 | 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- O- triphosphate ( ddTTP ) | 128524-26-5 |
| D 039 | 2', 3'- Dideoxyguanosine ( ddG ) | 085326-06-3 |
| D 040 | 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) | 3416-05-5 |
| D 041 | 3'- Deoxyguanosine ( 3'-dG ) | 3608-58-0 |
| D 042 | (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) | 339291-37-1 |
| D 043 | (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) | 339291-42-8 |
| D 044 | (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) | none |
| D 045 | (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) | none |
| D 046 | 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) | 80951-76-4 |
| D 047 | 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) | 80951-75-3 |
| D 048 | 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) | 876068-86-9 |
| D 049 | 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) | 876068-87-0 |
| D 050 | 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) | 62471-63-0 |
| D 051 | PKG inhibitor peptide DT-2 | pending |
| D 052 | PKG inhibitor peptide DT-3 | pending |
| D 054 | P1, P2- Di- (adenosine- 5')- diphosphate ( Ap2A / AppA ) | 85065-24-3 |
| D 055 | P1, P5- Di- (adenosine- 5')- pentaphosphate ( Ap5A / ApppppA ) | 4097-04-5 |
| D 056 | 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) | 87358-26-7 |
| D 057 | 2'- Deoxyuridine- 5'- O- monophosphorothioate ( 5'-dUMPS ) | 205379-91-5 |
| D 058 | 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP / 5'-dTuMP ) | 103078-56-4 |
| D 059 | 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) | 64145-27-3 |
| D 060 | 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) | 771477-45-3 |
| D 061 | 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP / 5'-dTuDP ) | 187478-96-2 |
| D 062 | 2'- Deoxyinosine | 890-38-0 |
| D 063 | 2, 6- Dichloro- 2', 3', 5'- triacetylpurine riboside | 3056-18-6 |
| D 064 | 2, 6- Dichloropurine riboside | 13276-52-3 |
| D 065 | 2'- Deoxyguanosine | 961-07-9 |
| D 069 | 4, 6- Dinitrobenzimidazole riboside- 3', 5'- cyclic monophosphate (4,6-DN-cBIMP) | pending |
| D 073 | 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-dcAMP ) | 81356-81-2 |
| D 074 | 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) | 73449-07-7 |
| D 075 | N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) | 64649-87-2 |
| D 076 | 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) | 67313-23-9 |
| D 077 | 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ε-5'-dAMP ) | 60508-81-8 |
| D 078 | 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) | 81004-54-8 |
| D 079 | 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) | 64183-27-3 |
| D 080 | 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) | 68498-25-9 |
| D 081 | 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP ) | pending |
| D 082 | 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) | pending |
| D 083 | 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) | 91828-83-0 |
| D 084 | 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) | 127383-33-9 |
| D 085 | 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) | 128113-53-1 |
| D 086 | 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) | 124615-99-2 |
| D 087 | 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP / 8-DY547-cGMP ) | pending |
| D 089 | 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) | pending |
| D 090 | 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) | pending |
| D 091 | 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP / 5'-TuDP ) | 21080-53-5 |
| D 092 | 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) | 16174-58-6 |
| D 093 | 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) | 4682-43-3 |
| D 094 | 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) | 16174-59-7 |
| D 096 | 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) | 10058-66-9 |
| D 099 | 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) | 81611-03-2 |
| D 101 | 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) | pending |
| D 104 | 2'- Deoxy- N6- (2- phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-dATP ) | 1239610-11-7 |
| D 108 | 8- Dimethylamino- cyclic inosine diphosphate ribose ( 8-DMA-N1-cIDPR ) | pending |
| D 109 | 8- (2- [DY-547]- aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cAMP / fcAMP ) | pending |
| D 110 | PKG inhibitor peptide (D)-DT-2 | pending |
| D 111 | 2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) | pending |
| D 112 | 2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) | pending |
| D 113 | 8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) | 1357147-61-5 |
| D 114 | 6- (ß- D- 2- Deoxyribofuranosyl)- 3, 4- dihydro- 8H- pyrimido- [4, 5- c]- [1, 2]- oxazin- 7- one- 5'- O- triphosphate ( 2'-Deoxy-P-nucleoside-5'-O-triphosphate / dPTP ) | 173964-83-5 |
| D 115 | P1, P4- Di- (adenosine- 5')- tetraphosphate ( Ap4A / AppppA ) | 5542-28-9 |
| D 116 | 2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) | pending |
| D 117 | P1, P3- Di- (adenosine- 5')- triphosphate ( Ap3A / ApppA ) | 5959-90-0 |
| D 119 | P1, P4- Di- (guanosine- 5')- tetraphosphate ( Gp4G / GppppG ) | 4130-19-2 |
| D 121 | 2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) | pending |
| D 122 | 2', 2''- O- ( Di- (6- [biotinyl]aminohexylcarbamoyl))- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) | pending |
| D 127 | P1, P2- Di- (cytidine- 5')- diphosphate ( Cp2C / CppC ) | 29789-88-6 |
| D 128 | P1, P2- Di- (uridine- 5')- diphosphate ( Up2U / UppU ) | 26184-65-6 |
| D 129 | P1, P4- Di- (uridine- 5')- tetraphosphate ( Up4U / UppppU ) | 59985-21-6 |
| D 132 | 2'- , 2''- Dideoxy- 2'-, 2''- difluoro- cyclic diadenosine monophosphate ( 2',2''-Di-F-c-didAMP ) | pending |
| D 135 | 2'- O- (6- [DY505-05]- aminohexylcarbamoyl))guanosine-3',5'-cyclic monophosphate ( 2'-[DY-505-05]-AHC-cGMP ) | pending |
| D 136 | 2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) | 849214-02-4 |
| D 139 | 2'-, 2''- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) | 60307-63-3 |
| D 140 | 2'- , 2''- Dideoxy- cyclic diadenosine monophosphate ( 2',2''-Di-c-didAMP ) | 79192-34-0 |
| D 143 | 2'- Deoxy- 2''- O- methyl- cyclic diadenosine monophosphate ( c-di-2'-d-2''-O-Me-AMP / c-(2'-dAp-2'-O-Me-Ap) ) | pending |
| D 144 | 2'- Deoxy- cyclic diadenosine monophosphate ( c-di-2'-dAMP / c-(2'-dApAp) ) | pending |
| D 145 | 2'- Deoxy- cyclic diguanosine monophosphate ( c-di-2'-dGMP / c-(2'-dGpGp) / c-dG-GMP ) | 132182-18-4 |
| D 148 | ß- ara- 2'- Deoxy- 2'- fluoro- nicotinamide adenine dinucleotide ( ara-2'-F-NAD+ ) | 133575-27-6 |
| D 154 | 2'- , 2''- O- ( Di- methyl)- cyclic diadenosine monophosphate ( 2',2''-Di-O-Me-c-diAMP ) | 1427269-46-2 |
| D 159 | 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diadenosine monophosphate ( Di-MANT-c-diAMP ) | pending |
| D 160 | P1, P5- Di- (inosine- 5')- pentaphosphate ( Ip5I / IpppppI ) | 1294478-76-4 |
| E 001 | 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) | 103213-51-0 |
| E 004 | 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) | 60777-99-3 |
| E 005 | 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) | 103213-41-8 |
| E 007 | 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) | 103213-52-1 |
| E 010 | Ethanolamine; immobilized on agarose gel ( EtOH-NH-Agarose ) | pending |
| E 011 | 1, N6- Ethenoadenosine ( ε-Ado ) | 39007-51-7 |
| E 012 | 1, N6- Ethenoadenine ( ε-Ade ) | 13875-63-3 |
| E 013 | 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( ε-ADPR / ε-ADP-ribose ) | 69699-76-9 |
| E 016 | 1, N6- Ethenoadenosine- 5'- O- diphosphoribose phosphate ( ε-ADPRP ) | 98088-66-5 |
| F 001 | 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cGMP / 8-[Fluo]-AET-cGMP ) | pending |
| F 002 | 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cAMP / 8-[Fluo]-AET-cAMP ) | 293296-57-8 |
| F 003 | 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP / FAM-cAMP ) | pending |
| F 004 | 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP / FAM-cGMP ) | pending |
| F 006 | N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ) | pending |
| F 007 | N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ) / Kinetin triphosphate ( KTP ) | 1450894-16-2 |
| F 008 | N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-γ-S ) | 1400539-83-4 |
| F 009 | 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) | pending |
| F 010 | 2'- / 3'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'- / 3'-Fluo-AHC-5'-AMP ) | pending |
| F 011 | 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) | pending |
| F 012 | 8- (6- [ Fluoresceinyl]aminohexylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-AHT-PET-cGMP ) | [pending] |
| G 001 | Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) | 40732-48-7 |
| G 002 | Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) | 164007-71-0 |
| G 012 | Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) | 71481-44-2 |
| G 013 | Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) | 71481-45-3 |
| G 014 | Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) | 81570-50-5 |
| G 015 | Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) | 81570-51-6 |
| G 016 | Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp-cGMPS ) | 86562-09-6 |
| G 017 | Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) | 86562-10-9 |
| G 018 | Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) | 76310-16-2 |
| G 019 | Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) | 37589-80-3 |
| G 021 | Guanosine- 3'- O- monophosphate ( 3'-GMP ) | 6027-83-4 |
| G 022 | Guanosine- 2'- O- monophosphate ( 2'-GMP ) | 130-50-7 |
| G 023 | Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) | 71376-97-1 |
| G 024 | Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) | 32381-15-0 |
| G 025 | Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ) | 15718-49-7 |
| G 026 | Guanosine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( GTP-γ-AmNS ) | 76724-84-0 |
| G 027 | P1- (5'- Guanosyl)- P4- (5'- uridyl)- tetraphosphate ( Gp4U / Up4G ) | 79695-25-3 |
| G 028 | Guanosine- 5'- O- diphosphate, immobilized on a polymeric matrix ( GDP-Gel / GDP-Agarose ) | pending |
| H 001 | 8- Hydroxyguanosine ( 8-OH-Guo ) | 3868-31-3 |
| H 002 | 8- Hydroxyguanine ( 8-OH-Gua ) | 5614-64-2 |
| H 003 | 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) | 31356-95-3 |
| H 004 | 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) | 475084-30-1 |
| H 005 | 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) | 749843-87-6 |
| H 006 | 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) | 59212-44-1 |
| H 007 | 8- Hydroxyadenine ( 8-OH-Ade ) | 21149-26-8 |
| H 010 | 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) | 612513-15-2 |
| H 011 | 8- Hydroxyadenosine ( 8-OH-Ado ) | 29851-57-8 |
| H 012 | 6- Hexylthioguanosine- 3', 5'- cyclic monophosphate ( 6-HT-cGMP ) | pending |
| H 013 | 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) | pending |
| H 016 | 8- Hydroxyguanosine- 3', 5'- cyclic monophosphate ( 8-OH-cGMP ) | 21082-28-0 |
| H 017 | 2- Hydroxyadenine ( 2-OH-Ade ) | 3373-53-3 |
| I 001 | Inosine- 3', 5'- cyclic monophosphate ( cIMP ) | 41092-64-2 |
| I 004 | 5- Iodotubercidin ( 5-I-Tu ) / 7- Deaza- 7- iodoadenosine | 24386-93-4 |
| I 005 | 2', 3'- Isopropylideneinosine | 2140-11-6 |
| I 006 | Inosine | 58-63-9 |
| I 007 | 2', 3'- Isopropylideneguanosine ( 2',3'-Ipr-Guo ) | 362-76-5 |
| K 001 | Ko-Libri Library of Nucleosides and Nucleobases | none |
| K 002 | Ko-Libri Library of Cyclic Nucleotides | none |
| M 001 | 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) | 33823-18-6 |
| M 003 | N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) | 70253-67-7 |
| M 004 | 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) | 152218-23-0 |
| M 005 | 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) | 152218-23-0 |
| M 006 | 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cGMP ) | 58329-72-9 |
| M 007 | 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cAMP ) | 55443-13-5 |
| M 008 | 2'- O- (N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) | 83707-14-6 |
| M 009 | 2'- O- (N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) | 83707-15-7 |
| M 010 | N2- Methylguanosine- 3', 5'- cyclic monophosphate ( 2-Me-cGMP) | 205368-54-3 |
| M 011 | 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) | 36940-87-1 |
| M 012 | N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) | 84433-46-5 |
| M 015 | 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) | 39118-26-8 |
| M 016 | 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) | 909782-76-9 |
| M 017 | N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) | 723313-27-7 |
| M 020 | 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP / 2-MeSADP ) | 34983-48-7 |
| M 021 | 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP / 2-MeSATP ) | 43170-89-4 |
| M 022 | 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) | 60448-20-6 |
| M 023 | 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) | 104872-93-7 |
| M 024 | N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ) | 681175-78-0 |
| M 025 | N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3-MeBn)-ATP ) | 215321-95-2 |
| M 026 | N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ) | pending |
| M 027 | N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ) | 252889-13-7 |
| M 028 | N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ) | 681175-77-9 |
| M 029 | N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ) | 252889-14-8 |
| M 030 | 2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) | 151481-86-6 |
| M 031 | 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP / 2-MeSAMP ) | 22140-20-1 |
| M 032 | 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) | 148821-03-8 |
歡迎下載下面的資料以了解此產(chǎn)品的相關(guān)信息!預(yù)詢產(chǎn)品訂購信息
上海普邁生物致力于提供高質(zhì)量的產(chǎn)品和服務(wù)組織形態(tài)學(xué)研究與競爭力的產(chǎn)品
產(chǎn)品和服務(wù),有相關(guān)產(chǎn)品的問題請直接
期貨每周下午5點前發(fā)定單,正常到上海時間為3-4周
現(xiàn)市區(qū)2天內(nèi)送到,外地以快遞為準(zhǔn)
敬請關(guān)注!
:
:pumaibio
:pumaibio
:(直接客戶)
(經(jīng)銷商)
*etonbio、polysciences、Mattek、trevigen、Chromogenix、cyguns、IrvineScientific、Innovative Cell Technologies、enzo、novus、immunochemistry、eylabs、Polyplus、NIBSC、ALZET、hitobiotec、sutter instrument、mirus、StressMarq、Avanti、jena bioscience、Neuro Probe、tedpella、avanti、Rockland、CAYMAN、transgenomic、BioLegend、ambion、omicronbio、
Assaybiotech、chondrex、lc?laboratories、cosmobio、megazyme、NeoMarkers、BTI、eylabs、berryassoc、cellagentech、TOCRIS、Relia Tech、SouthernBiotech、Biosearch technology、Lumiprobe、StemCells?Inc、biovendor、NORGEN、alomone、jena?bioscience、Gracebio、Eurogentec、Gelcompany?、invitrogen、gene?bridges、MRC-Holland、laysanbio
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),儀表網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。